Protumor role of estrogen receptor expression in oral squamous cell carcinoma cells-Reference-Cited by-同舟云学术

Protumor role of estrogen receptor expression in oral squamous cell carcinoma cells

Published:2021-11 Issue:5 Volume:132 Page:549-565
ISSN:2212-4403
Container-title:Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
language:en
Short-container-title:Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Author:

Akyu (Takei) Rie,Tomihara Kei^ORCID,Yamazaki Manabu^ORCID,Moniruzzaman Rohan,Heshiki Wataru,Sekido Katsuhisa,Tachinami Hidetake,Sakurai Kotaro,Yonesi Amirmoezz,Imaue Shuichi,Fujiwara Kumiko,Noguchi Makoto

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Dentistry (miscellaneous),Pathology and Forensic Medicine,Oral Surgery,Surgery

Reference47 articles.

1. Cancer of the oral cavity;Montero;Surg Oncol Clin N Am,2015

2. Prognostic significance of lymph node density in squamous cell carcinoma of the tongue;Ong;Head Neck,2016

3. Advances in oral cancer detection;Chakraborty;Adv Clin Chem,2019

4. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

5. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck;Soulieres;J Clin Oncol,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma;Scientific Reports;2024-06-18

2. The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors;Cancers;2024-04-19

3. A Robust Statistical Approach for Finding Informative Spatially Associated Pathways;2024-04-01

4. Determination of the anticancer activity of standardized extract of Centella asiatica (ECa 233) on cell growth and metastatic behavior in oral cancer cells;Research in Pharmaceutical Sciences;2024-03

5. The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide;2023-11-17